Your browser doesn't support javascript.
loading
Increased prostacyclin levels inhibit the aggregation and activation of platelets via the PI3K-AKT pathway in prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation.
Zhang, Xiao-Hui; Zhou, Shi-Yuan; Feng, Ru; Wang, Ya-Zhe; Kong, Yuan; Zhou, Yi; Zhang, Jia-Min; Wang, Min; Zhao, Jing-Zhong; Wang, Qian-Ming; Feng, Fei-Er; Zhu, Xiao-Lu; Wang, Feng-Rong; Wang, Jing-Zhi; Han, Wei; Chen, Huan; Xu, Lan-Ping; Liu, Yan-Rong; Liu, Kai-Yan; Huang, Xiao-Jun.
Afiliação
  • Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China; Collaborative Innovation Center of Hematology, Peking University, People's Republic of China. Electronic address: zhangxh100@sina.com.
  • Zhou SY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China; Collaborative Innovation Center of Hematology, Peking University, People's Republic of China.
  • Feng R; Department of Hematology, Beijing Hospital, Ministry of Health, Beijing, People's Republic of China.
  • Wang YZ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Kong Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Zhou Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Zhang JM; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Wang M; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Zhao JZ; Peking University People's Hospital, Department of Clinical Laboratory, Beijing, People's Republic of China.
  • Wang QM; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Feng FE; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Zhu XL; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Wang FR; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Wang JZ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Han W; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Chen H; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Liu YR; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China.
  • Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, People's Republic of China; Collaborative Innovation Center of Hematology, Peking University, People's Republic of China.
Thromb Res ; 139: 1-9, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26916289

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Trombocitopenia / Ativação Plaquetária / Epoprostenol / Transplante de Células-Tronco Hematopoéticas / Fosfatidilinositol 3-Quinases / Proteínas Proto-Oncogênicas c-akt Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Thromb Res Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Trombocitopenia / Ativação Plaquetária / Epoprostenol / Transplante de Células-Tronco Hematopoéticas / Fosfatidilinositol 3-Quinases / Proteínas Proto-Oncogênicas c-akt Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Thromb Res Ano de publicação: 2016 Tipo de documento: Article